whether patients should undergo genetic testing to determine their warfarin dose
October 2007
Experts are now debating whether patients should undergo genetic testing to determine their warfarin dose.
Most clinicians titrate warfarin doses by trial and error.
Now the FDA is suggesting lower doses for patients with certain genetic variations.
Get concise, unbiased advice for effective drug therapy, plus CE/CME
Prescriber's Letter includes:
- 12 issues every year, with brief articles about new meds and guidelines
- 48+ CE courses, including the popular CE-in-the-Letter
- Quick reference drug comparison charts
- Access to the entire archive
Already a subscriber? Log in
Volume pricing available. Get a quote